Westport, CT – According to filings with the U.S. Securities and Exchange Commission, BioSig Technologies is raising $3,600,000.00 in a new round of investment. Sources indicate as part of senior management Chairman and Chief Executive Officer, Kenneth Londoner played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About BioSig Technologies

At BioSig, we’re working to develop and deliver the advanced signal processing solutions that will unlock the future of bioelectronic medicine, starting with the PURE EP System. We built BioSig to achieve this vision with a strong commitment to research, a world-class leadership team, and a network of expert partners. We are now achieving important milestones as we prepare to enter the fast-growing electrophysiology market, but our aspirations reach even further: to lead one of the most innovative and most promising frontiers in healthcare.

To learn more about BioSig Technologies, visit http://www.biosig.com/

Contact:
Kenneth Londoner, Chairman and Chief Executive Officer
203-409-5444
klondoner@biosigtech.com
https://www.linkedin.com/in/ken-londoner-mba-5912274/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved